Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 432

1.

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.

Krasniqi E, Barchiesi G, Pizzuti L, Mazzotta M, Venuti A, Maugeri-Saccà M, Sanguineti G, Massimiani G, Sergi D, Carpano S, Marchetti P, Tomao S, Gamucci T, De Maria R, Tomao F, Natoli C, Tinari N, Ciliberto G, Barba M, Vici P.

J Hematol Oncol. 2019 Oct 29;12(1):111. doi: 10.1186/s13045-019-0798-2. Review.

2.

Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.

Veschi V, Mangiapane LR, Nicotra A, Di Franco S, Scavo E, Apuzzo T, Sardina DS, Fiori M, Benfante A, Colorito ML, Cocorullo G, Giuliante F, Cipolla C, Pistone G, Bongiorno MR, Rizzo A, Tate CM, Wu X, Rowlinson S, Stancato LF, Todaro M, De Maria R, Stassi G.

Oncogene. 2019 Oct 7. doi: 10.1038/s41388-019-1047-4. [Epub ahead of print]

PMID:
31591478
3.

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.

Orienti I, Salvati V, Sette G, Zucchetti M, Bongiorno-Borbone L, Peschiaroli A, Zolla L, Francescangeli F, Ferrari M, Matteo C, Bello E, Di Virgilio A, Falchi M, De Angelis ML, Baiocchi M, Melino G, De Maria R, Zeuner A, Eramo A.

J Exp Clin Cancer Res. 2019 Aug 22;38(1):373. doi: 10.1186/s13046-019-1383-9.

4.

PTEN Tumor-Suppressor: The Dam of Stemness in Cancer.

Luongo F, Colonna F, Calapà F, Vitale S, Fiori ME, De Maria R.

Cancers (Basel). 2019 Jul 30;11(8). pii: E1076. doi: 10.3390/cancers11081076. Review.

5.

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors.

Orienti I, Francescangeli F, De Angelis ML, Fecchi K, Bongiorno-Borbone L, Signore M, Peschiaroli A, Boe A, Bruselles A, Costantino A, Eramo A, Salvati V, Sette G, Contavalli P, Zolla L, Oki T, Kitamura T, Spada M, Giuliani A, Baiocchi M, La Torre F, Melino G, Tartaglia M, De Maria R, Zeuner A.

Cell Death Dis. 2019 Jul 23;10(7):529. doi: 10.1038/s41419-019-1775-y.

6.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583. [Epub ahead of print]

PMID:
31330065
7.

Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.

Goeman F, De Nicola F, Scalera S, Sperati F, Gallo E, Ciuffreda L, Pallocca M, Pizzuti L, Krasniqi E, Barchiesi G, Vici P, Barba M, Buglioni S, Casini B, Visca P, Pescarmona E, Mazzotta M, De Maria R, Fanciulli M, Ciliberto G, Maugeri-Saccà M.

J Thorac Oncol. 2019 Nov;14(11):1924-1934. doi: 10.1016/j.jtho.2019.07.003. Epub 2019 Jul 16.

PMID:
31323387
8.

Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction.

Scardovi AB, De Maria R, Galeotti GG, Faggiano P, Arcari L, Ghio S, Temporelli PL, Rossi A, Magni G, Simioniuc A, Ricci R, Dini FL.

Monaldi Arch Chest Dis. 2019 Jul 18;89(2). doi: 10.4081/monaldi.2019.1045.

9.

Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.

Argano M, De Maria R, Rodlsberger K, Buracco P, Menzies MPL.

Can J Vet Res. 2019 Apr;83(2):149-153.

10.

[ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU consensus document: The clinical care pathway of acute heart failure patients from symptom onset to discharge from the emergency department].

Mortara A, Gabrielli D, Pugliese FR, Corcione A, Perticone F, Fontanella A, Mercuro G, Cricelli C, Iacoviello M, D'Ambrosio G, Guarracino F, Modesti PA, Vescovo G, De Maria R, Iacovoni A, Macera F, Palmieri V, Pasqualucci D, Battistoni I, Alunni G, Aspromonte N, Caldarola P, Campanini M, Caporale R, Casolo G, Cipriani M, Di Tano G, Domenicucci S, Murrone A, Nardi F, Navazio A, Oliva F, Parretti D, Urbinati S, Valente S, Valeriano V, Zuin G, Metra M, Sinagra G, Gulizia MM, Di Lenarda A.

G Ital Cardiol (Rome). 2019 May;20(5):289-334. doi: 10.1714/3151.31321. Italian.

PMID:
31066371
11.

Establishment of three-dimensional canine osteosarcoma cell lines showing vasculogenic mimicry and evaluation of biological properties after treatment with 17-AAG.

Massimini M, De Maria R, Malatesta D, Romanucci M, D'Anselmo A, Della Salda L.

Vet Comp Oncol. 2019 Sep;17(3):376-384. doi: 10.1111/vco.12482. Epub 2019 Jun 13.

PMID:
31006970
12.

Canine mammary tumour cells exposure to sevoflurane: effects on cell proliferation and neuroepithelial transforming gene 1 expression.

Argano M, De Maria R, Vogl C, Rodlsberger K, Buracco P, Larenza Menzies MP.

Vet Anaesth Analg. 2019 May;46(3):369-374. doi: 10.1016/j.vaa.2018.12.006. Epub 2019 Feb 6.

PMID:
31000496
13.

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.

Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R.

Mol Cancer. 2019 Mar 30;18(1):70. doi: 10.1186/s12943-019-0994-2. Review.

14.

Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments.

Iannolo G, Sciuto MR, Cuscino N, Pallini R, Douradinha B, Vitiani LR, De Maria R, Conaldi PG.

Cell Death Dis. 2019 Mar 19;10(4):263. doi: 10.1038/s41419-019-1499-z.

15.

The Italian-Canine Cancer Biobank: Our 10-year challenge.

Aresu L, Buracco P, De Maria R, Iussich S, Martano M, Morello E, Bettini G, Comazzi S, Riondato F, Marconato L.

Hematol Oncol. 2019 Aug;37(3):314-315. doi: 10.1002/hon.2602. Epub 2019 Mar 28. No abstract available.

16.

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.

Grassi L, Alfonsi R, Francescangeli F, Signore M, De Angelis ML, Addario A, Costantini M, Flex E, Ciolfi A, Pizzi S, Bruselles A, Pallocca M, Simone G, Haoui M, Falchi M, Milella M, Sentinelli S, Di Matteo P, Stellacci E, Gallucci M, Muto G, Tartaglia M, De Maria R, Bonci D.

Cell Death Dis. 2019 Feb 27;10(3):201. doi: 10.1038/s41419-019-1453-0.

17.

Coping, Mood, Quality of Life, and Outcomes in Recipients of Left Ventricular Assist Devices: A Cluster Analysis.

Modica M, Minotti A, De Maria R, Scaglione A, Bordoni B, Cipriani M, Russo C, Racca V, Ferratini M.

Psychosom Med. 2019 Feb/Mar;81(2):192-199. doi: 10.1097/PSY.0000000000000658.

PMID:
30625121
18.

Expression of the Short Form of RON/STK in Feline Mammary Carcinoma.

Maniscalco L, Guil-Luna S, Iussich S, Gattino F, Trupia C, Millan Y, de Las Mulas JM, Cespedez RS, Saeki K, Accornero P, De Maria R.

Vet Pathol. 2019 Mar;56(2):220-229. doi: 10.1177/0300985818806967. Epub 2018 Dec 17.

PMID:
30558510
19.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Aroldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
20.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

Gamucci T, Pizzuti L, Natoli C, Mentuccia L, Sperduti I, Barba M, Sergi D, Iezzi L, Maugeri-Saccà M, Vaccaro A, Magnolfi E, Gelibter A, Barchiesi G, Magri V, D'Onofrio L, Cassano A, Rossi E, Botticelli A, Moscetti L, Omarini C, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Mazzotta M, Bria E, Foglietta J, Samaritani R, Garufi C, Mariani L, Barni S, Mirabelli R, Sarmiento R, Graziano V, Santini D, Marchetti P, Tonini G, Di Lauro L, Sanguineti G, Paoletti G, Tomao S, De Maria R, Veltri E, Paris I, Giotta F, Latorre A, Giordano A, Ciliberto G, Vici P.

Cancer Biol Ther. 2019;20(2):192-200. doi: 10.1080/15384047.2018.1523095. Epub 2018 Nov 7.

21.

Two-Step Co-Immunoprecipitation (TIP).

Sciuto MR, Coppola V, Iannolo G, De Maria R, Haas TL.

Curr Protoc Mol Biol. 2019 Jan;125(1):e80. doi: 10.1002/cpmb.80. Epub 2018 Oct 30.

PMID:
30375742
22.

[ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure].

Di Tano G, Di Lenarda A, Gabrielli D, Aspromonte N, De Maria R, Frigerio M, Iacoviello M, Mortara A, Murrone A, Nardi F, Oliva F, Pontremoli R, Scherillo M, Senni M, Urbinati S, Gulizia MM.

G Ital Cardiol (Rome). 2018 Oct;19(10):568-590. doi: 10.1714/2978.29843. Italian.

PMID:
30281045
23.

Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study.

Gori M, Redfield MM, Calabrese A, Canova P, Cioffi G, De Maria R, Grosu A, Fontana A, Iacovoni A, Ferrari P, Parati G, Gavazzi A, Senni M.

Eur J Heart Fail. 2018 Nov;20(11):1540-1548. doi: 10.1002/ejhf.1298. Epub 2018 Sep 17.

24.

The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression.

Buglioni S, Melucci E, Sperati F, Pallocca M, Terrenato I, De Nicola F, Goeman F, Casini B, Amoreo CA, Gallo E, Diodoro MG, Pescarmona E, Vici P, Sergi D, Pizzuti L, Di Lauro L, Mazzotta M, Barba M, Fanciulli M, Vitale I, De Maria R, Ciliberto G, Maugeri-Saccà M.

Oncoimmunology. 2018 Apr 24;7(8):e1457602. doi: 10.1080/2162402X.2018.1457602. eCollection 2018.

25.

Renal cancer: new models and approach for personalizing therapy.

di Martino S, De Luca G, Grassi L, Federici G, Alfonsi R, Signore M, Addario A, De Salvo L, Francescangeli F, Sanchez M, Tirelli V, Muto G, Sperduti I, Sentinelli S, Costantini M, Pasquini L, Milella M, Haoui M, Simone G, Gallucci M, De Maria R, Bonci D.

J Exp Clin Cancer Res. 2018 Sep 5;37(1):217. doi: 10.1186/s13046-018-0874-4.

26.

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.

Pallocca M, Goeman F, De Nicola F, Melucci E, Sperati F, Terrenato I, Pizzuti L, Casini B, Gallo E, Amoreo CA, Vici P, Di Lauro L, Buglioni S, Diodoro MG, Pescarmona E, Mazzotta M, Barba M, Fanciulli M, De Maria R, Ciliberto G, Maugeri-Saccà M.

J Transl Med. 2018 Sep 4;16(1):247. doi: 10.1186/s12967-018-1607-3.

27.

Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.

Oliva F, Perna E, Marini M, Nassiacos D, Cirò A, Malfatto G, Morandi F, Caico I, Perna G, Meloni S, Vincenzi A, Villani A, Vecchi AL, Minoia C, Verde A, De Maria R; RELEVANT-HF study group.

Int J Cardiol. 2018 Dec 1;272:255-259. doi: 10.1016/j.ijcard.2018.08.048. Epub 2018 Aug 16.

PMID:
30131229
28.

Replication stress response in cancer stem cells as a target for chemotherapy.

Manic G, Sistigu A, Corradi F, Musella M, De Maria R, Vitale I.

Semin Cancer Biol. 2018 Dec;53:31-41. doi: 10.1016/j.semcancer.2018.08.003. Epub 2018 Aug 3. Review.

PMID:
30081229
29.

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer.

De Nicola F, Goeman F, Pallocca M, Sperati F, Pizzuti L, Melucci E, Casini B, Amoreo CA, Gallo E, Diodoro MG, Buglioni S, Mazzotta M, Vici P, Sergi D, Di Lauro L, Barba M, Pescarmona E, Ciliberto G, De Maria R, Fanciulli M, Maugeri-Saccà M.

Oncogenesis. 2018 Jul 22;7(7):55. doi: 10.1038/s41389-018-0066-2.

30.

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models.

Del Curatolo A, Conciatori F, Cesta Incani U, Bazzichetto C, Falcone I, Corbo V, D'Agosto S, Eramo A, Sette G, Sperduti I, De Luca T, Marabese M, Shirasawa S, De Maria R, Scarpa A, Broggini M, Del Bufalo D, Cognetti F, Milella M, Ciuffreda L.

J Exp Clin Cancer Res. 2018 Jul 9;37(1):140. doi: 10.1186/s13046-018-0820-5.

31.

Efficient, Efficacious, Effective: Still a Long Way to Go for Diuretic Treatment of Acute Decompensated Heart Failure.

De Maria R.

J Card Fail. 2018 Jul;24(7):439-441. doi: 10.1016/j.cardfail.2018.06.002. Epub 2018 Jun 25. No abstract available.

PMID:
29953939
32.

[Peripartum cardiomyopathy: a little known disease].

Scardovi AB, De Maria R.

G Ital Cardiol (Rome). 2018 Apr;19(4):209-221. doi: 10.1714/2898.29215. Review. Italian.

PMID:
29912235
33.

Promotion of Home-Based Exercise Training as Secondary Prevention of Coronary Heart Disease: A PILOT WEB-BASED INTERVENTION.

Torri A, Panzarino C, Scaglione A, Modica M, Bordoni B, Redaelli R, De Maria R, Ferratini M.

J Cardiopulm Rehabil Prev. 2018 Jul;38(4):253-258. doi: 10.1097/HCR.0000000000000316.

PMID:
29738378
34.

Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members.

Villanova L, Careccia S, De Maria R, Fiori ME.

Int J Mol Sci. 2018 Mar 23;19(4). pii: E958. doi: 10.3390/ijms19040958. Review.

35.

PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.

Gattino F, Maniscalco L, Iussich S, Biasato I, Martano M, Morello E, Gola C, Millán Ruiz Y, Saeki N, Buracco P, Martín de Las Mulas J, De Maria R.

Vet Rec. 2018 Aug 18;183(7):221. doi: 10.1136/vr.104414. Epub 2018 Feb 9.

PMID:
29440590
36.

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.

Melucci E, Casini B, Ronchetti L, Pizzuti L, Sperati F, Pallocca M, De Nicola F, Goeman F, Gallo E, Amoreo CA, Sergi D, Terrenato I, Vici P, Di Lauro L, Diodoro MG, Pescarmona E, Barba M, Mazzotta M, Mottolese M, Fanciulli M, Ciliberto G, De Maria R, Buglioni S, Maugeri-Saccà M.

J Transl Med. 2018 Feb 5;16(1):22. doi: 10.1186/s12967-018-1385-y.

37.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

38.

miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2.

Fiori ME, Villanova L, Barbini C, De Angelis ML, De Maria R.

Cell Death Dis. 2018 Jan 19;9(2):49. doi: 10.1038/s41419-017-0080-x.

39.

Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.

Sette G, Salvati V, Giordani I, Pilozzi E, Quacquarini D, Duranti E, De Nicola F, Pallocca M, Fanciulli M, Falchi M, Pallini R, De Maria R, Eramo A.

Int J Cancer. 2018 Jul 1;143(1):88-99. doi: 10.1002/ijc.31260. Epub 2018 Jan 26.

40.

HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.

di Martino S, Amoreo CA, Nuvoli B, Galati R, Strano S, Facciolo F, Alessandrini G, Pass HI, Ciliberto G, Blandino G, De Maria R, Cioce M.

Oncogene. 2018 Mar;37(10):1369-1385. doi: 10.1038/s41388-017-0044-8. Epub 2018 Jan 9.

PMID:
29311642
41.

In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.

Gatti M, Solari A, Pattarozzi A, Campanella C, Thellung S, Maniscalco L, De Maria R, Würth R, Corsaro A, Bajetto A, Ratto A, Ferrari A, Daga A, Barbieri F, Florio T.

Exp Cell Res. 2018 Feb 1;363(1):48-64. doi: 10.1016/j.yexcr.2018.01.002. Epub 2018 Jan 4.

PMID:
29305964
42.

The Hippo pathway in normal development and cancer.

Maugeri-Saccà M, De Maria R.

Pharmacol Ther. 2018 Jun;186:60-72. doi: 10.1016/j.pharmthera.2017.12.011. Epub 2018 Jan 3. Review.

PMID:
29305295
43.

Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.

Di Tano G, Caretta G, De Maria R, Bettari L, Parolini M, Testa S, Pirelli S.

Biomark Med. 2018 Jan;12(1):21-26. doi: 10.2217/bmm-2017-0178. Epub 2017 Dec 15.

PMID:
29243525
44.

Colorectal cancer: towards new challenges and concepts of preventive healthcare.

Colace L, Boccia S, De Maria R, Zeuner A.

Ecancermedicalscience. 2017 Nov 28;11:ed74. doi: 10.3332/ecancer.2017.ed74. eCollection 2017.

45.

Two-Step Coimmunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein Complexes.

Sciuto MR, Warnken U, Schnölzer M, Valvo C, Brunetto L, Boe A, Biffoni M, Krammer PH, De Maria R, Haas TL.

Mol Cell Proteomics. 2018 May;17(5):993-1009. doi: 10.1074/mcp.O116.065920. Epub 2017 Dec 7.

46.

Replication stress in colorectal cancer stem cells.

Manic G, De Maria R, Vitale I.

Oncotarget. 2017 May 20;8(53):90606-90607. doi: 10.18632/oncotarget.18045. eCollection 2017 Oct 31. No abstract available.

47.

[Cardiogenic shock is a rare disease: the dedicated network].

Valente S, Marini M, Battistoni I, Sorini Dini C, Di Mario C, De Maria R, Aspromonte N, Cacciavillani L, Ferraiuolo G, Iacoviello M, Casolo G, Di Lenarda A, Gulizia MM.

G Ital Cardiol (Rome). 2017 Oct;18(10):719-726. doi: 10.1714/2790.28261. Review. Italian.

PMID:
29105686
48.

[Cardiogenic shock: from pharmacological treatment to mechanical circulatory support].

Battistoni I, Marini M, Lavorgna A, Vagnarelli F, Lucà F, Biscottini E, Caretta G, Procaccini V, Riva L, Vianello G, Iacoviello M, De Maria R, Navazio A, Aspromonte N, Di Lenarda A, Gulizia MM, Valente S.

G Ital Cardiol (Rome). 2017 Oct;18(10):708-718. doi: 10.1714/2790.28260. Review. Italian.

PMID:
29105685
49.

[Cardiogenic shock: from early diagnosis to multiparameter monitoring].

Marini M, Battistoni I, Lavorgna A, Vagnarelli F, Lucà F, Biscottini E, Caretta G, Procaccini V, Riva L, Vianello G, Mortara A, Pini D, De Maria R, Aspromonte N, Di Lenarda A, Gulizia MM, Valente S.

G Ital Cardiol (Rome). 2017 Oct;18(10):696-707. doi: 10.1714/2790.28259. Review. Italian.

PMID:
29105684
50.

Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.

Sánchez-Céspedes R, Millan Y, Guil-Luna S, García-Macías J, Maniscalco L, Iussich S, De Maria R, M de Las Mulas J.

J Vet Diagn Invest. 2018 Jan;30(1):155-160. doi: 10.1177/1040638717735867. Epub 2017 Oct 11.

Supplemental Content

Loading ...
Support Center